Achilles Corporation

TSE:5142 Stock Report

Market Cap: JP¥20.8b

Achilles Past Earnings Performance

Past criteria checks 0/6

Achilles's earnings have been declining at an average annual rate of -69.3%, while the Chemicals industry saw earnings growing at 9.4% annually. Revenues have been growing at an average rate of 0.5% per year.

Key information

-69.3%

Earnings growth rate

-70.2%

EPS growth rate

Chemicals Industry Growth6.6%
Revenue growth rate0.5%
Return on equity-16.1%
Net Margin-8.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Achilles (TSE:5142) Is Paying Out A Dividend Of ¥20.00

Nov 13
Achilles (TSE:5142) Is Paying Out A Dividend Of ¥20.00

Achilles (TSE:5142) Has Announced That Its Dividend Will Be Reduced To ¥20.00

Mar 28
Achilles (TSE:5142) Has Announced That Its Dividend Will Be Reduced To ¥20.00

Achilles' (TSE:5142) Shareholders Will Receive A Smaller Dividend Than Last Year

Feb 27
Achilles' (TSE:5142) Shareholders Will Receive A Smaller Dividend Than Last Year

Revenue & Expenses Breakdown

How Achilles makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:5142 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2479,263-6,77614,4400
30 Jun 2478,787-8,06714,5090
31 Mar 2478,607-8,21014,5890
31 Dec 2379,144-8,91914,7160
30 Sep 2380,299-1,21614,8580
30 Jun 2382,381-1,51915,0110
31 Mar 2382,917-1,20415,1300
31 Dec 2283,16572115,3450
30 Sep 2280,3221,17615,1160
30 Jun 2277,3021,43014,9120
31 Mar 2275,9531,52514,6010
31 Dec 2175,6031,43614,4650
30 Sep 2175,9461,51814,4370
30 Jun 2175,5631,69014,3850
31 Mar 2173,6173,21514,2880
31 Dec 2073,5893,29414,2990
30 Sep 2074,3913,48314,3430
30 Jun 2076,7883,36314,5910
31 Mar 2080,2251,89514,9440
31 Dec 1981,8651,31015,1120
30 Sep 1984,61525815,4970
30 Jun 1985,30123415,5390
31 Mar 1985,70533815,6360
31 Dec 1886,73869815,5140
30 Sep 1886,1311,76715,3390
30 Jun 1886,9811,84115,4290
31 Mar 1887,9102,28415,7380
31 Dec 1789,7192,31016,1200
30 Sep 1788,8222,46416,0260
30 Jun 1787,9102,49415,8650
31 Mar 1786,9371,97415,4590
31 Dec 1685,8551,78215,1480
30 Sep 1687,0201,50715,2190
30 Jun 1688,0131,56715,2740
31 Mar 1688,3442,54315,3080
31 Dec 1589,0522,42815,5690
30 Sep 1589,2482,10215,4920
30 Jun 1589,2422,47515,2420
31 Mar 1589,0561,28715,1370
31 Dec 1490,0951,90214,8880
30 Sep 1489,1952,05914,7810
30 Jun 1489,0811,59714,8670
31 Mar 1488,0061,73414,7860
31 Dec 1384,5491,48614,7240

Quality Earnings: 5142 is currently unprofitable.

Growing Profit Margin: 5142 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 5142 is unprofitable, and losses have increased over the past 5 years at a rate of 69.3% per year.

Accelerating Growth: Unable to compare 5142's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 5142 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (14%).

Return on Equity

High ROE: 5142 has a negative Return on Equity (-16.09%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y